1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,310 | 2,600 | 13:05 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.10. | Careium AB: Careium reports third quarter results 2025 | 73 | GlobeNewswire (Europe) | The third quarter in summaryNet sales increased by 6.0 percent to SEK 213.7 million (201.7)Net sales increased by 9.4 percent adjusted for currency effectsNet sales increased despite a negative impact... ► Artikel lesen | |
| 18.08. | Careium AB: President & CEO Christian Walén steps down from his position and Peter Heuman appointed as interim CEO | 280 | GlobeNewswire (Europe) | Careium's Board of Directors and Careium's President and CEO Christian Walén have mutually agreed that Christian Walén steps down from the role of President and CEO, effective immediately.
"The Board... ► Artikel lesen | |
| 11.07. | Careium AB: Careium reports second quarter results 2025 | 167 | GlobeNewswire (Europe) | The second quarter in summary
Net sales decreased 11.9 percent to SEK 202.1 million (229.4)Reported net sales was negatively impacted with SEK 15.1 million by the accounting of financial leases in Sweden... ► Artikel lesen | |
| 13.06. | Careium AB: Bulletin from the extraordinary general meeting on 13 June 2025 of Careium AB (publ) | 147 | GlobeNewswire (Europe) | The extraordinary general meeting ("EGM") of Careium AB (publ), 559121-5875, (the "Company") took place today, 13 June 2025.
The EGM resolved on all proposed matters in accordance with previously published... ► Artikel lesen | |
| CAREIUM Aktie jetzt für 0€ handeln | |||||
| 24.04. | Careium AB: Careium reports first quarter results 2025 | 100 | GlobeNewswire (Europe) | The First Quarter in Summary
Net sales decreased 1.6 percent to SEK 207.4 million (210.7)Service sales increased 3.4 percent to SEK 160.3 million (155.0)Product sales decreased 15.5 percent to SEK 47.1... ► Artikel lesen | |
| 13.02. | Careium AB: Careium reports fourth quarter results 2024 | 497 | GlobeNewswire (Europe) | The Fourth Quarter in SummaryNet sales increased 14.8 percent to SEK 228.9 million (199.4)Service sales was SEK 165.9 million (154.1)Product sales was SEK 63.0 million (45.3)Gross margin increased to... ► Artikel lesen |
6 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,380 | -0,59 % | Fresenius SE wackelt - dieser Boden sollte halten | Die Fresenius SE-Aktie steht kurz vor einer wichtigen Unterstützung. Hält der Bereich, oder droht ein Rückfall in tiefere Kursregionen Den vollständigen Artikel lesen ... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,460 | -0,16 % | BARCLAYS stuft Siemens Healthineers auf 'Positiv' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat das Kursziel für Siemens Healthineers von 61,00 auf 61,50 Euro angehoben und die Einstufung auf "Overweight" belassen. Die Aktienkurse... ► Artikel lesen | |
| THERMO FISHER | 515,30 | -0,31 % | Thermo Fisher Scientific Subsidiary Prices EUR 2.1 Bln Senior Notes Offering | HONG KONG (dpa-AFX) - Thermo Fisher Scientific Inc. (TMO) has priced an offering of 2.1 billion euros aggregate principal amount of euro-denominated notes, to be issued by Thermo Fisher Scientific... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 58,64 | -1,31 % | Eurofins Scientific SE: Director/PDMR Shareholding | Eurofins Scientific SE (EUFI.PA) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR"). The notification of Dealing Form for each PDMR can be... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| DAVITA | 104,15 | -0,76 % | DaVita: A Future Reimagined Through Choice, Trust and Empowerment | NORTHAMPTON, MA / ACCESS Newswire / November 25, 2025 / For Franz Nolan, hearing the words "kidney failure" brought back difficult memories. His father's long struggle with kidney disease made the idea... ► Artikel lesen | |
| DENTSPLY SIRONA | 9,630 | +0,44 % | Dentsply Sirona ticks up after interim CFO appointment | ||
| SMITH & NEPHEW | 14,575 | +0,24 % | SMITH & NEPHEW PLC - 6-K, Report of foreign issuer | ||
| SONIC HEALTHCARE | 12,940 | -1,22 % | SONIC HEALTHCARE LIMITED: Change of Director's Interest Notice | ||
| DIASORIN | 60,90 | +0,30 % | Milan: Strong day for DiaSorin | ||
| FULGENT GENETICS | 26,600 | -0,75 % | Raymond James erhöht Kursziel für Fulgent Genetics nach starken Zahlen auf 36 US-Dollar | ||
| IMPLANTICA | 4,790 | +3,68 % | Implantica: RefluxStop 'Best in Class' at Japan Foregut Conference as 5-Year Data and Extensive Safety Cohort is Presented to 120 Leading Surgeons | VADUZ, Liechtenstein, Nov. 25, 2025 /PRNewswire/ -- Implantica AG (publ), a medtech company at the forefront of introducing advanced technology into the body, announced today that its innovative... ► Artikel lesen | |
| PERSPECTIVE THERAPEUTICS | 1,930 | +1,58 % | UBS lowers Perspective Therapeutics stock price target on competition concerns | ||
| OMNICELL | 32,200 | 0,00 % | Why Omnicell Stock Crushed the Market Today | ||
| RENALYTIX | 0,072 | -0,69 % | Renalytix PLC - Plan to Implement ADS Ratio Change |
Das Unternehmen CAREIUM AB kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,320 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CAREIUM AB finden Sie auf Wallstreet Online.